Literature DB >> 6201546

Circulating cellfree Fc gamma 2b/gamma 1 receptor in normal mouse serum: its detection and specificity.

D Khayat, Z Dux, R Anavi, Y Shlomo, I P Witz, M Ran.   

Abstract

By using intact or Fab fragments of rat monoclonal antibodies against murine Fc gamma 2b/gamma 1 receptor, in a solid phase radioimmunoassay, we demonstrated the occurrence of circulating cellfree Fc gamma 2b/gamma 1 receptors (Cf-Fc gamma 2b/gamma 1R) in normal mouse serum. These Cf-Fc gamma 2b/gamma 1R were removed from serum by affinity chromatography by using Sepharose columns coupled with IgG but not by Sepharose coupled with F(ab')2 fragments. Furthermore, the material retained by and eluted from the Sepharose IgG column reacted with the monoclonal antibody; these results support a direct relationship between the antigenic and the functional Cf-Fc gamma 2b/gamma 1R that were detected in serum. This Cf-Fc gamma 2b/gamma 1R was found in all the 39 normal mouse sera that were tested. The results seemed to indicate that aging may be associated with increased levels of Cf-Fc gamma 2b/gamma 1R and that levels of circulating Fc gamma R may be under genetic regulation. By forming complexes with circulating IgG within the blood stream, such Cf-Fc gamma 2b/gamma 1R may modulate some of the functions in which the Fc portion of Ig is involved.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201546

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Murine soluble Fc gamma receptors/IgG-binding factors (IgG-BF): analysis of the relation to Fc gamma RII and production of milligram quantities of biologically active recombinant IgG-BF.

Authors:  C Sautès; N Mazières; A Galinha; E Tartour; C Bonnerot; S Amigorena; C Teillaud; R Spagnoli; W H Fridman
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Isolation and characterization of a high molecular weight lymphocyte Fc gamma receptor-blocking factor associated with renal allograft survival.

Authors:  G P Sandilands; J E Cocker; M A McMillan; A M Owsianka; H Marsden; B J Junor; J D Briggs; R N MacSween
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  Spontaneous release of Fc gamma receptors from normal human peripheral blood lymphocytes in vitro.

Authors:  J McGuire; G P Sandilands
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

4.  Pitfalls in the measurement of soluble forms of cell surface receptors.

Authors:  N R Ling
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

5.  The plasma protein which inhibits complement-mediated prevention of immune precipitation is an Fc binding protein.

Authors:  A E Ahmed; P Bird; I C McKay; K Whaley
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

6.  Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing mice.

Authors:  A Lynch; E Tartour; J L Teillaud; B Asselain; W H Fridman; C Sautès
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

7.  Fc receptors on mouse neutrophils and eosinophils: antigenic characteristics, isotype specificity and relative cell membrane density measured by flow cytometry.

Authors:  A F López; F L Battye; M A Vadas
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

Review 8.  FcR may function as a progression factor of nonlymphoid tumors.

Authors:  I P Witz; M Ran
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

9.  Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor.

Authors:  A Budkowska; C Quan; F Groh; P Bedossa; P Dubreuil; J P Bouvet; J Pillot
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction.

Authors:  F L Ierino; M S Powell; I F McKenzie; P M Hogarth
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.